Videos & Webinars - European Medical Journal

Continue

Video & Webinars

EMJ
Oncology
15 Oct 2015

ECC 2015: News briefing chaired by Prof Peter Naredi

At the European Cancer Congress (ECC) 2015, Peter Naredi, MD, PhD, of the University of Gothenburg, Gothenburg, Sweden, chairs a news briefing with…
EMJ
Oncology
15 Oct 2015

Phase 2 trial of TAK-385, an oral GnRH antagonist, in prostate cancer

At the European Cancer Congress (ECC) 2015, Neal Shore, MD, FACS, of Carolina Urologic Research Center, Myrtle Beach, SC, discusses the first interim…
EMJ
Oncology
15 Oct 2015

ECC 2015: Cancer healthcare inequalities between and within countries in Europe

There is a growing divide in cancer healthcare and survivorship between populations across Europe. European Cancer Patient Coalition (ECPC), the largest…
EMJ
Oncology
15 Oct 2015

TAILORx: Prospective phase 3 trial validating a 21-gene expression assay in breast cancer

At the European Cancer Congress (ECC) 2015, Clifford A. Hudis, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses the low-risk…
EMJ
Oncology
15 Oct 2015

ECC 2015: Challenging the European disparities in cancer care

European Cancer Patient Coalition (ECPC), the largest European cancer patients’ umbrella organisation, presented the paper, ‘Europe of Disparities in…
EMJ
Oncology
15 Oct 2015

ECC 2015: Hormonal therapy may prevent ovarian failure and preserve fertility in breast cancer

A meta-analysis was conducted to include 12 randomised trials and a total of 1,231 breast cancer patients receiving chemotherapy, with or without…
EMJ
Oncology
15 Oct 2015

Clinical access to genomic information in Europe

Genomic interventions may improve disease-risk stratification and patient-tailored treatment. At the European Cancer Congress (ECC) 2015, John Crown, MD…
EMJ
Oncology
14 Oct 2015

Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)

At the European Cancer Congress (ECC) 2015, John Crown, MD, MBA, of St Vincent’s University Hospital, Dublin, Ireland, discusses the low-risk registry…